Dan V. Iosifescu
Active 1996–2025
- 113
- Papers
- 18,607
- Citations
- 75
- h-index
- 106
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine40.5%
- Neuroscience33.1%
- Psychology11.9%
- Biochemistry, Genetics and Molecular Biology8.4%
- Computer Science3.4%
- Engineering0.5%
- Other2.2%
Topics
- Treatment of Major Depression11.4%
- Tryptophan and brain disorders9.3%
- Functional Brain Connectivity Studies5.7%
- Stress Responses and Cortisol4.2%
- Neurotransmitter Receptor Influence on Behavior3.7%
- Mental Health Research Topics3.4%
- Other62.3%
Coauthors
- James W. Murrough33
- Maurizio Fava33
- Sanjay J. Mathew25
- Katherine A. Collins20
- Dennis S. Charney19
- George I. Papakostas13
- Andrew A. Nierenberg11
- Diego A. Pizzagalli11
- Paolo Cassano10
- Roy H. Perlis10
- Cristina Cusin9
- Gerard Sanacora9
- Madhukar H. Trivedi9
- Andrew M. Perez8
- David Mischoulon8
- Charles DeBattista7
- Emily Stern7
- Lee C. Chang7
- Michael E. Thase7
- Sara Costi7
- Alexis E. Whitton6
- Brian M. Iacoviello6
- Jordan W. Smoller6
- Marlene P. Freeman6
All papers
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
Authors: Roger S. McIntyre, Joshua D. Rosenblat, Charles B. Nemeroff, Gerard Sanacora, James W. Murrough, Michael Berk, Elisa Brietzke, Seetal Dodd, Philip Gorwood, Roger Ho, Dan V. Iosifescu, Carlos López‐Jaramillo, Siegfried Kasper, Kevin Kratiuk, Jung Goo Lee, Yena Lee, Leanna M.W. Lui, Rodrigo B. Mansur, George I. Papakostas, Mehala Subramaniapillai, Michael E. Thase, Eduard Vieta, Allan H. Young, Carlos A. Zarate, Stephen M. Stahl - American Journal of Psychiatry 2021 cited by 689
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
Authors: James W. Murrough, Dan V. Iosifescu, Lee C. Chang, Rayan K. Al Jurdi, Charles E. Green, Andrew M. Perez, Syed Iqbal, Sarah Pillemer, Alexandra L. Foulkes, Asim A. Shah, Dennis S. Charney, Sanjay J. Mathew - American Journal of Psychiatry 2013 cited by 1,205
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Authors: Maurizio Fava, Marlene P. Freeman, Martina Flynn, Heidi Judge, Bettina B. Hoeppner, Cristina Cusin, Dawn F. Ionescu, Sanjay J. Mathew, Lee C. Chang, Dan V. Iosifescu, James W. Murrough, Charles DeBattista, Alan F. Schatzberg, Madhukar H. Trivedi, Manish K. Jha, Gerard Sanacora, Samuel T. Wilkinson, George I. Papakostas - Molecular Psychiatry 2018 cited by 437
- Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Authors: Amir Garakani, James W. Murrough, Rafael C. Freire, Robyn P. Thom, Kaitlyn Larkin, Frank D. Buono, Dan V. Iosifescu - FOCUS The Journal of Lifelong Learning in Psychiatry 2020 cited by 412
- Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals With Major Depressive Disorder
Authors: Diego A. Pizzagalli, Avram J. Holmes, Daniel G. Dillon, Elena L. Goetz, Jeffrey L. Birk, Ryan Bogdan, Darin D. Dougherty, Dan V. Iosifescu, Scott L. Rauch, Maurizio Fava - American Journal of Psychiatry 2009 cited by 1,254
- A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia
Authors: Andrew D. Krystal, Diego A. Pizzagalli, Moria J. Smoski, Sanjay J. Mathew, John I. Nürnberger, Sarah H. Lisanby, Dan V. Iosifescu, James W. Murrough, Hongqiu Yang, Richard D. Weiner, Joseph R. Calabrese, Gerard Sanacora, Gretchen Hermes, Richard S.E. Keefe, Allen W. Song, Wayne K. Goodman, Steven T. Szabo, Alexis E. Whitton, Keming Gao, William Z. Potter - Nature Medicine 2020 cited by 229
- Reduced hedonic capacity in major depressive disorder: Evidence from a probabilistic reward task
Authors: Diego A. Pizzagalli, Dan V. Iosifescu, Lindsay A. Hallett, Kyle G. Ratner, Maurizio Fava - Journal of Psychiatric Research 2008 cited by 797
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
Authors: James W. Murrough, Andrew M. Perez, Sarah Pillemer, Jessica Stern, Michael K. Parides, Marije aan het Rot, Katherine A. Collins, Sanjay J. Mathew, Dennis S. Charney, Dan V. Iosifescu - Biological Psychiatry 2012 cited by 785
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Authors: Kyle Lapidus, Cara F. Levitch, Andrew M. Perez, Jess W. Brallier, Michael K. Parides, Laili Soleimani, Adriana Feder, Dan V. Iosifescu, Dennis S. Charney, James W. Murrough - Biological Psychiatry 2014 cited by 482
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
Authors: Adriana Feder, Michael K. Parides, James W. Murrough, Andrew M. Perez, Julia E. Morgan, Shireen Saxena, Katherine Kirkwood, Marije aan het Rot, Kyle Lapidus, Le-Ben Wan, Dan V. Iosifescu, Dennis S. Charney - JAMA Psychiatry 2014 cited by 616
- Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double‐blind randomized controlled trial
Authors: Abraham Zangen, Hagar Moshe, Diana Martínez, Noam Barnea‐Ygael, Tanya Vapnik, Alexander Bystritsky, Walter Duffy, Doron Toder, Leah Casuto, Moran Lipkinsky Grosz, Edward V. Nunes, Herbert E. Ward, Aron Tendler, David Feifel, Oscar Morales, Yiftach Roth, Dan V. Iosifescu, Jaron L. Winston, Theodore Wirecki, Ahava Stein, Frederic Deutsch, Xingbao Li, Mark S. George - World Psychiatry 2021 cited by 234
- Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial
Authors: Herriot Tabuteau, Amanda Jones, Ashley Anderson, Mark Z. Jacobson, Dan V. Iosifescu - American Journal of Psychiatry 2022 cited by 133
- Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder
Authors: Dan V. Iosifescu, Amanda Jones, Cedric O’Gorman, Caroline Streicher, Samantha Feliz, Maurizio Fava, Herriot Tabuteau - The Journal of Clinical Psychiatry 2022 cited by 127
- Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo‐Controlled Phase 3 Trial
Authors: Anita H. Clayton, Robert Lasser, Sagar V. Parikh, Dan V. Iosifescu, JungAh Jung, Mona Kotecha, Fiona Forrestal, Jeffrey M. Jonas, Stephen Kanes, James Doherty - American Journal of Psychiatry 2023 cited by 75
- Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
Authors: Sara Costi, Laurel Morris, Katherine Kirkwood, Megan Hoch, Morgan Corniquel, Brittany Vo‐Le, Tabish Iqbal, Nisha Chadha, Diego A. Pizzagalli, Alexis E. Whitton, Laura Bevilacqua, Manish K. Jha, Stefan Ursu, Alan C. Swann, Katherine A. Collins, Ramiro Salas, Emilia Bagiella, Michael K. Parides, Emily Stern, Dan V. Iosifescu, Ming‐Hu Han, Sanjay J. Mathew, James W. Murrough - American Journal of Psychiatry 2021 cited by 82
- A mega-analysis of genome-wide association studies for major depressive disorder
Authors: Stephan Ripke, Naomi R. Wray, Cathryn M. Lewis, Steven P. Hamilton, Myrna M. Weissman, Gerome Breen, Enda M. Byrne, Douglas Blackwood, Dorret I. Boomsma, Sven Cichon, Andrew C. Heath, Florian Holsboer, Susanne Lucae, Pamela A. F. Madden, Nicholas G. Martin, Peter McGuffin, Pierandrea Muglia, Markus M. Nöethen, Brenda P Penninx, Michele L. Pergadia, James B. Potash, Marcella Rietschel, D. Y. Lin, Bertram Müller‐Myhsok, Jianxin Shi, Stacy Steinberg, Hans J. Grabe, Paul Lichtenstein, Patrik K. E. Magnusson, Roy H. Perlis, Martin Preisig, Jordan W. Smoller, Kāri Stefánsson, Rudolf Uher, Zoltán Kutalik, Katherine E. Tansey, Alexander Teumer, Alexander Viktorin, Michael R. Barnes, Thomas Bettecken, Elisabeth B. Binder, René Breuer, Víctor M. Castro, Susanne Churchill, William Coryell, Nick Craddock, Ian Craig, Darina Czamara, Eco J. C. de Geus, Franziska Degenhardt, Anne Farmer, Maurizio Fava, Josef Frank, Vivian S. Gainer, Patience Gallagher, Scott D. Gordon, Sergey Goryachev, Magdalena Groß, Michel Guipponi, Anjali K. Henders, Stefan Herms, Ian B. Hickie, Susanne Hoefels, Witte J.G. Hoogendijk, Jouke‐Jan Hottenga, Dan V. Iosifescu, Marcus Ising, Ian D. Jones, Lisa Jones, Tzeng Jung-Ying, James A. Knowles, Isaac S. Kohane, Martin Kohli, Ania Korszun, Mikael Landén, William Lawson, Glyn Lewis, Donald J. MacIntyre, Wolfgang Maier, Manuel Mattheisen, Patrick J. McGrath, Andrew M. McIntosh, Alan McLean, Christel M. Middeldorp, Lefkos Middleton, Grant M Montgomery, Shawn N. Murphy, Matthias Nauck, Willem A. Nolen, Dale R. Nyholt, Michael O‘Donovan, Högni Óskarsson, Nancy L. Pedersen, William A. Scheftner, Andrea Schulz, Thomas G. Schulze, Stanley I. Shyn, Engilbert Sigurðsson, Susan L. Slager, Johannes H. Smit and 16 more - Molecular Psychiatry 2012 cited by 1,169
- Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
Authors: Drew D. Kiraly, Sarah R. Horn, Nicholas T. Van Dam, Sara Costi, Jaclyn Schwartz, Seunghee Kim‐Schulze, Manishkumar Patel, Georgia E. Hodes, Scott J. Russo, Miriam Mérad, Dan V. Iosifescu, Dennis S. Charney, James W. Murrough - Translational Psychiatry 2017 cited by 181
- Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
Authors: Colin N. Haile, James W. Murrough, Dan V. Iosifescu, Lee C. Chang, Rayan K. Al Jurdi, Alexandra L. Foulkes, Sidra Iqbal, James J. Mahoney, Richard De La Garza, Dennis S. Charney, Thomas F. Newton, Sanjay J. Mathew - The International Journal of Neuropsychopharmacology 2013 cited by 250
- Ketamine Treatment and Global Brain Connectivity in Major Depression
Authors: Chadi G. Abdallah, Lynnette A. Averill, Katherine A. Collins, Paul Geha, Jaclyn Schwartz, Christopher L. Averill, Kaitlin E. DeWilde, Edmund Wong, Alan Anticevic, Cheuk Y. Tang, Dan V. Iosifescu, Dennis S. Charney, James W. Murrough - Neuropsychopharmacology 2016 cited by 305
- Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial
Authors: Paolo Cassano, Samuel Petrie, David Mischoulon, Cristina Cusin, Husam A. Katnani, Albert Yeung, Luis De Taboada, Abigal Archibald, Éric Bui, Lee Baer, Trina Chang, Justin A. Chen, Paola Pedrelli, Lauren Fisher, Amy Farabaugh, Michael R. Hamblin, Jonathan E. Alpert, Maurizio Fava, Dan V. Iosifescu - Photomedicine and Laser Surgery 2018 cited by 151
- Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder
Authors: Aaron Tan, Sara Costi, Laurel Morris, Nicholas T. Van Dam, Marin Kautz, Alexis E. Whitton, Allyson K. Friedman, Katherine A. Collins, Gabriella M. Ahle, Nisha Chadha, Brian Do, Diego A. Pizzagalli, Dan V. Iosifescu, Eric J. Nestler, Ming‐Hu Han, James W. Murrough - Molecular Psychiatry 2018 cited by 77
- Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model
Authors: Roy H. Perlis, Dan V. Iosifescu, Víctor M. Castro, Shawn N. Murphy, Vivian S. Gainer, Jessica Minnier, Tianxi Cai, Sergey Goryachev, Qibing Zeng, Patience Gallagher, Maurizio Fava, Jeffrey B. Weilburg, Susanne Churchill, Isaac S. Kohane, Jordan W. Smoller - Psychological Medicine 2011 cited by 201
- RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)
Authors: Gregory M. Chandler, Dan V. Iosifescu, Mark H. Pollack, Steven D. Targum, Maurizio Fava - CNS Neuroscience & Therapeutics 2009 cited by 156
- Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study
Authors: Paolo Cassano, Cristina Cusin, David Mischoulon, Michael R. Hamblin, Luis De Taboada, Angela Pisoni, Trina Chang, Albert Yeung, Dawn F. Ionescu, Samuel Petrie, Andrew A. Nierenberg, Maurizio Fava, Dan V. Iosifescu - Psychiatry Journal 2015 cited by 122
